Insulin aspart
Insulin aspart is an active ingredient of the class «insulin analog».
Pharmaceutical drug
What it is used for
- Maturity-onset diabetes of the young type 2
- Hyperglycemia
- Type-1 diabetes
- Diabetes
NOVOLOG MIX 70/30 is a mixture of insulin aspart protamine and insulin aspart indicated to improve glycemic control in adult patients with diabetes mellitus. Limitations of Use: NOVOLOG MIX 70/30 is not recommended for the treatment of diabetic ketoacidosis.
Treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above.
How it works
- Insulin receptor agonist
Class: insulin analog
Common side effects
The trial was a three-month, open-label trial in patients with type 1 or type 2 diabetes who were treated twice daily (before breakfast and before supper) with NOVOLOG MIX 70/30. Table 1: Adverse Reactions that Occurred in ≥ 5% of Type 1 Diabetes Mellitus Adult Patients Treated with NOVOLOG MIX 70/30 NOVOLOG MIX…
Who should not take it
NOVOLOG MIX 70/30 is contraindicated: During episodes of hypoglycemia In patients with hypersensitivity to NOVOLOG MIX 70/30 or one of its excipients Do not use during episodes of hypoglycemia.
Pregnancy and breastfeeding
There are no available data with NOVOLOG MIX 70/30 in pregnant women to inform a drug-associated risk for major birth defects and miscarriage.
Interactions
- Clonidine
- Clozapine
- Epinephrine
- Fluoxetine
- Glucagon
- Isoniazid
- Lithium carbonate
- Octreotide
- Olanzapine
- Pentamidine
- Pentoxifylline
- Salbutamol
- Terbutaline
Brand names
United States
Fiasp · Fiasp Flextouch · Fiasp Penfill · Novolog · Novolog Flexpen · Novolog Flextouch · Novolog Innolet · Novolog Penfill
European Union
Dazparda · Fiasp · Insulin aspart Sanofi · Kirsty (previously Kixelle) · NovoMix · NovoRapid
Canada
Fiasp · Kirsty · Novorapid · Trurapi
Other trade names
Ins novorapid
Approval status
- US Food and Drug Administration
- prescription · since 2000
- European Medicines Agency
- authorised · since 1999
- Health Canada
- prescription · marketed
- First approval anywhere
- 1999
Codes
- ATC
- A10AB05, A10AD05
- RxNorm CUI
- 51428
- ChEMBL
- CHEMBL1201496
- PubChem CID
- 118984445
- Wikidata
- Q2754775
Frequently asked questions
What is Insulin aspart used for?
Insulin aspart is used for: Maturity-onset diabetes of the young type 2, Hyperglycemia, Type-1 diabetes, and Diabetes.
What kind of medicine is Insulin aspart?
Insulin aspart is an active ingredient of the class «insulin analog».
What are the brand names of Insulin aspart?
Brand names of Insulin aspart include Fiasp, Fiasp Flextouch, Fiasp Penfill, Novolog, Novolog Flexpen, Novolog Flextouch, Novolog Innolet, and Novolog Penfill.
Medicines in the same class
Sources and licences
- ChEMBL (CC BY-SA 3.0)
- Wikidata (CC0 1.0)
- openFDA / DailyMed (public domain)
- European Medicines Agency (reuse with acknowledgement)
- Health Canada Drug Product Database (Open Government Licence – Canada)